Opioid Use Disorder study: Low Threshold Buprenorphine
Official title Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
ClinicalTrials.gov ID: NCT07631598
What this study is testing
- What it's testing
- The study aims to find out if providing buprenorphine directly at syringe service programs leads to better treatment participation than referring patients to outside clinics. It also looks at how easy it is to run this program and if it is cost-effective.
- Who it's for
- Adults with opioid use disorder who currently use syringe service programs.
- What's involved
- Participants will receive either a referral to a community provider or start buprenorphine treatment directly at the syringe service program. Researchers will collect health information before and after the new program begins.
- Time commitment
- The study involves data collection before and after the new program starts at each location, with no specific total duration listed.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- ≥ 18 years old;
- Meet DSM-5 criteria for moderate or severe OUD;
- Interest in receiving buprenorphine treatment;
- Speaks English or Spanish;
- Currently an SSP client at the time of enrollment;
You likely can't join if
- Current use of prescribed opioid agonist treatment, as assessed by self-report, at the time of enrollment;
- Unstable mental health or medical condition that requires an immediate clinical evaluation or higher level of care;
- Allergy to buprenorphine;
- Currently detained in jail, prison, residential substance use treatment facility, or other overnight facility as required by court of law.
See the full eligibility criteria
- ≥ 18 years old;
- Meet DSM-5 criteria for moderate or severe OUD;
- Interest in receiving buprenorphine treatment;
- Speaks English or Spanish;
- Currently an SSP client at the time of enrollment;
- Ability to provide informed consent.
- Current use of prescribed opioid agonist treatment, as assessed by self-report, at the time of enrollment;
- Unstable mental health or medical condition that requires an immediate clinical evaluation or higher level of care;
- Allergy to buprenorphine;
- Currently detained in jail, prison, residential substance use treatment facility, or other overnight facility as required by court of law.
The study team makes the final eligibility decision.
Where it is enrolling
- Los Angeles, California, United States
- Washington D.C., District of Columbia, United States
- Baton Rouge, Louisiana, United States
- Duluth, Minnesota, United States
- Roswell, New Mexico, United States
- Grants Pass, Oregon, United States
- Greenville, South Carolina, United States
- Milwaukee, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Los Angeles, California, United States; Washington D.C., District of Columbia, United States; Baton Rouge, Louisiana, United States; Duluth, Minnesota, United States; Roswell, New Mexico, United States; Grants Pass, Oregon, United States and 2 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.